BrightSpring Health Services, Inc. Common Stock (BTSG)vsMangoceuticals, Inc. Common Stock (MGRX)
BTSG
BrightSpring Health Services, Inc. Common Stock
$57.40
0.00%
HEALTHCARE · Cap: $11.97B
MGRX
Mangoceuticals, Inc. Common Stock
$0.38
-2.09%
HEALTHCARE · Cap: $6.35M
Smart Verdict
WallStSmart Research — data-driven comparison
BrightSpring Health Services, Inc. Common Stock generates 3291462% more annual revenue ($13.65B vs $414,580). BTSG leads profitability with a 2.3% profit margin vs 0.0%. BTSG earns a higher WallStSmart Score of 53/100 (C-).
BTSG
Buy53
out of 100
Grade: C-
MGRX
Avoid23
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 359.8% YoY
Revenue surging 25.6% year-over-year
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
2.3% margin — thin
Operating margin of 3.4%
Elevated debt levels
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BTSG
The strongest argument for BTSG centers on EPS Growth, Revenue Growth. Revenue growth of 25.6% demonstrates continued momentum.
Bull Case : MGRX
The strongest argument for MGRX centers on Price/Book, Debt/Equity.
Bear Case : BTSG
The primary concerns for BTSG are Profit Margin, Operating Margin, Debt/Equity. A P/E of 79.2x leaves little room for execution misses. Thin 2.3% margins leave little buffer for downturns.
Bear Case : MGRX
The primary concerns for MGRX are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
BTSG profiles as a growth stock while MGRX is a value play — different risk/reward profiles.
MGRX carries more volatility with a beta of 2.27 — expect wider price swings.
BTSG is growing revenue faster at 25.6% — sustainability is the question.
BTSG generates stronger free cash flow (101M), providing more financial flexibility.
Bottom Line
BTSG scores higher overall (53/100 vs 23/100) and 25.6% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BrightSpring Health Services, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, specializing in the care of diverse patient populations, including individuals with intellectual and developmental disabilities and those in need of rehabilitation. The company is committed to delivering personalized, high-quality care through a skilled workforce, which contributes to improved patient outcomes and enhances quality of life. With a focus on strategic investments in innovative technologies and a robust approach to value-based care, BrightSpring is well-positioned to thrive in the dynamic healthcare environment and capitalize on emerging market opportunities.
Visit Website →Mangoceuticals, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. The company is headquartered in Dallas, Texas.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?